Alzheimer’s Drug Development Revolution: Inflammation and Tau Take Center Stage as Amyloid Era Fades
The 2024 pipeline report reveals a dramatic shift from amyloid to inflammation and tau targets, with repurposed drugs and combination therapies leading a new era of Alzheimer’s treatment. New report shows Alzheimer’s drug trials pivot fro...
Alzheimer’s Drug Development Revolution: Inflammation and Tau Take Center Stage as Amyloid Era Fades
The 2024 pipeline report reveals a dramatic shift from amyloid to inflammation and tau targets, with repurposed drugs and combination therapies leading a new era of Alzheimer’s treatment. New re...
New research shows modifiable lifestyle factors add up to 7 years of life expectancy in older adults, even those with high genetic risk. A landmark study reveals that diet, exercise, and not smoking c...
A March 2025 study in Cell Reports Medicine finds that muscle loss from GLP-1 drugs mirrors ordinary weight loss, alleviating public concern. A new study reassures that GLP-1 drugs do not cause dispro...
AI4L 1.0 uses audit-driven prompting to produce hallucination-free, citation-verified longevity reviews, addressing widespread distrust in AI health advice. Forever Healthy’s AI4L 1.0 promises to re...
New research links inflammaging and immunosenescence to Alzheimer’s and Parkinson’s, with immune-modulating therapies showing early promise. Aging of the immune system accelerates brain di...
Explore how partial reprogramming using Yamanaka factors reverses epigenetic aging, with recent advances in mice and early clinical trials paving the way for rejuvenation therapies. Partial reprogramm...
New research reveals that pulsed electromagnetic fields can activate gene therapy in aged mice, improving survival and reducing aging markers, but ethical questions loom. A groundbreaking study demons...
A major study reveals aging is a coordinated epigenetic program, not random damage. Single-cell ATAC-seq of 7 million cells shows stereotyped changes across organs, with therapeutic implications. New ...
Recent studies reveal that immune aging, or ‘inflammaging,’ is a modifiable risk factor for neurodegenerative diseases, with new biomarkers and senolytic drugs offering hope for early inte...
A new study in Aging Cell uncovers a bidirectional feedback loop between intestinal aging and gut microbiome changes, accelerating systemic inflammation. A study in Aging Cell reveals how age-related ...









